Joong-Soo Han

Dr. Joong-Soo Han

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DMD Massenburg
D Massenburg
JHJoong-Soo Han
Joong-Soo Han
MLM Liyanage
M Liyanage
WPW A Patton
W A Patton
SRS G Rhee
S G Rhee
MVM Vaughan
M Vaughan
Two major forms of phospholipase D (PLD) activity, solubilized from rat brain membranes with Triton X-100, were separated by HPLC on a heparin-5PW column with buffer containing octyl glucoside. One form was completely dependent on sodium oleate for activity. The other, which was dramatically activated by the addition of ADP-ribosylation factor (ARF) 1 and guanine 5' [gamma-thio]triphosphate, required the presence of phosphatidylinositol 4,5-bisphosphate in the phosphatidylcholine substrate for demonstration of activity, as described by others. Oleate-dependent activity was unaffected by guanine 5' [gamma-thio]triphosphate, or phosphatidylinositol 4,5-bisphosphate. Both sodium oleate-and ARF-dependent activities catalyzed transphosphatidylation, thus identifying them as PLDs. ARF-dependent PLD was activated by recombinant ARF5 (class II) and ARF6 (class III), as well as ARF1 (class I). Myristoylated recombinant ARFs were more effective than their nonmyristoylated counterparts. ARFs were originally identified as activators of cholera toxin ADP-ribosyltransferase activity. The effects of recombinant ARF proteins from the three classes on cholera toxin activity (assayed under conditions identical to those used to assay PLD activity) did not, however, correlate with those on PLD, consistent with the notion that different aspects of ARF structure are involved in the two functions.

20 December 2000 in Cancer Letters
Verified
Journal Article
Closed access
DND Y Noh
D Y Noh
SAS J Ahn
S J Ahn
RLR A Lee
R A Lee
IPI A Park
I A Park
JKJ H Kim
J H Kim
JHJoong-Soo Han
Joong-Soo Han

1 June 2011 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
HKHyeon Soo Kim
Hyeon Soo Kim
YLYu-Mi Lim
Yu-Mi Lim
WQWenying Quan
Wenying Quan
JKJung Ran Kim
Jung Ran Kim
KCKun Wook Chung
Kun Wook Chung
MLMyung-Shik Lee
Myung-Shik Lee
Myoung Sook Han, Yu-Mi Lim, Wenying Quan, Jung Ran Kim, Kun Wook Chung, Mira Kang, Sunshin Kim, Sun Young Park, Joong-Soo Han, Shin-Young Park, Hyae Gyeong Cheon, Sang Dal Rhee, Tae-Sik Park, Myung-Shik Lee

1 June 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JCJoon-Ki Chung
Joon-Ki Chung
FSFujio Sekiya
Fujio Sekiya
HKHeun-Soo Kang
Heun-Soo Kang
CLChunghee Lee
Chunghee Lee
JHJoong-Soo Han
Joong-Soo Han
SRSue Goo Rhee
Sue Goo Rhee
A 150-kDa protein that inhibits phospholipase D (PLD) activity stimulated by ADP-ribosylation factor and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) was previously purified from rat brain. The sequences of peptides derived from the purified PLD inhibitor now identify it as synaptojanin, a nerve terminal protein that has been implicated in the endocytosis of fused synaptic vesicles and shown to be a member of the inositol polyphosphate 5-phosphatase family. Further characterization of the enzymatic properties of synaptojanin now shows that it hydrolyzes only the 5-phosphate from inositol 1,4,5-trisphosphate (I(1,4,5)P3) and that it does not catalyze the dephosphorylation of either I(1,3,4)P3 or inositol 1,4-bisphosphate. However, synaptojanin hydrolyzes both the 4- and 5-phosphates of PI(4,5)P2 and the 4-phosphate of phosphatidylinositol 4-phosphate, converting both compounds to phosphatidylinositol. Magnesium is required for the hydrolysis of I(1,4,5)P3, but not for that of phosphoinositides, by synaptojanin. The inhibition of PLD by synaptojanin is attributable to its ability to hydrolyze PI(4,5)P2. Synaptojanin did not inhibit PLD in the absence of PI(4,5)P2, and the extent of PLD inhibition was related to the extent of PI(4,5)P2hydrolysis in substrate vesicles. It has been proposed that the biosynthesis of PI(4,5)P2 and the activation of PLD by ADP-ribosylation factor constitute a positive loop to increase rapidly the concentrations of PI(4,5)P2 and phosphatidic acid (PA) during membrane vesiculation. The PA thus produced, probably together with PI(4,5)P2, facilitates vesicle coat assembly. The hydrolysis of PI(4,5)P2, and consequent inhibition of PLD, by synaptojanin might therefore constitute a mechanism to halt the positive loop connecting PI(4,5)P2 and PA during the endocytotic cycle of synaptic vesicles and serve as a signal for uncoating.

1 March 2009 in Cell Metabolism
Verified
Journal Article
Closed access
Dongryeol RyuDongryeol Ryu
Dongryeol Ryu
Kyoung-Jin OhKyoung-Jin Oh
Kyoung-Jin Oh
HJHee-Yeon Jo
Hee-Yeon Jo
SHSusan Hedrick
Susan Hedrick
YKYo-Na Kim
Yo-Na Kim
SKSeung-Hoi Koo
Seung-Hoi Koo

4 July 2018 in Molecular Brain
Verified
Journal Article
Open access
PDF file
SPShin-Young Park
Shin-Young Park
MKMin-Jeong Kang
Min-Jeong Kang
JHJoong-Soo Han
Joong-Soo Han
Pro-inflammatory cytokine interleukin-1 beta (IL-1β) is a key mediator of inflammation and stress in the central nervous system (CNS), and is highly expressed in the developing brain. In this study, we investigated the possible role of IL-1β in neuronal differentiation of cortical neural precursor cells (NPCs). We showed that stimulation with IL-1β increased expression levels of neurotrophin-3 (NT3) and neurogenin 1 (Ngn1) and promoted neurite outgrowth. We also found that IL-1β increased mRNA and protein levels of Wnt5a. Knockdown of Wnt5a by transfection with Wnt5a siRNA inhibited IL-1β-induced neuronal differentiation. Moreover, IL-1β-induced Wnt5a expression was regulated by nuclear factor kappa B (NF-κB) activation, which is involved in IL-1β-mediated neuronal differentiation. To examine the role of Wnt5a in neuronal differentiation of NPCs, we exogenously added Wnt5a. We found that exogenous Wnt5a promotes neuronal differentiation, and activates the RhoA/Rho-associated kinase (ROCK)/c-jun N-terminal kinase (JNK) pathway. In addition, Wnt5a-induced neuronal differentiation was blocked by RhoA siRNA, as well as by a specific Rho-kinase inhibitor (Y27632) or a SAPK/JNK inhibitor (SP600125). Furthermore, treatment with RhoA siRNA, Y27632, or SP600125 suppressed the IL-1β-induced neuronal differentiation. Therefore, these results suggest that the sequential Wnt5a/RhoA/ROCK/JNK pathway is involved in IL-1β-induced neuronal differentiation of NPCs.